Skip to main content

Table 2 Relationship between MAGE and clinical variables by univariate regression analysis

From: Nerve conduction study of the association between glycemic variability and diabetes neuropathy

 

r

Spearman ρ

p value

Age (years)

0.028

 

0.86

Disease duration (years)

0.462

 

0.003

HbA1c (%)

0.292

 

0.067

BMI (kg/m2)

− 0.39

 

0.012

SBP (mmHg)

0.045

 

0.78

TG (mg/dL)

− 0.18

 

0.27

LDL (mg/dL)

0.40

 

0.011

eGFR (mL/min/1.73 m2)

0.014

 

0.70

UAE (mg/gCre)

 

0.13

0.41

Median CMAP amp (mV)

− 0.098

 

0.55

Median DL (m/s)

0.032

 

0.84

Median MCV (m/s)

− 0.27

 

0.088

Median F latency z score

0.057

 

0.72

Median wrist SNAP (µV)

− 0.228

 

0.158

Median SCV (m/s)

− 0.00

 

0.99

Tibial CMAP amp (mV)

0.12

 

0.46

Tibial MCV (m/s)

− 0.043

 

0.79

Tibial F z score

− 0.25

 

0.12

Sural SNAP (µV)

− 0.15

 

0.37

Sural SCV (m/s)

0.055

 

0.74

Medial plantar CNAP amp (µV)

− 0.32

 

0.042

Medial plantar NCV (m/s)

− 0.033

 

0.849

  1. HbA1c glycated hemoglobin A1c, BMI body mass index, SBP systolic blood pressure, TG triglyceride, LDL low-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, UAE urinary albumin excretion, MAGE mean amplitude of glycemic excursions, CMAP compound muscle action potential, SNAP sensory nerve action potential, CNAP compound nerve action potential, amp: amplitude, DL distal latency, MCV motor nerve conduction velocity, SCV sensory nerve conduction velocity, NCV nerve conduction velocity